Newfeed

SAN DIEGO, Jan. 7, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with CrossLink Life Sciences, LLC to expand the sales network supporting ZYNRELEF® (bupivacain

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: